Literature DB >> 17448701

Differences between systematic reviews/meta-analyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee.

J Campbell1, N Bellamy, T Gee.   

Abstract

OBJECTIVE: To explore reasons for discrepant results between systematic reviews (SR)/meta-analyses (MA) of the efficacy and safety of hyaluronic acid/hyaluronan/hylan (HA) therapy in the treatment of osteoarthritis (OA) of the knee.
METHODS: A decision algorithm was utilised to identify reasons for discordance among six SR. Sources of discordance such as clinical question, trial selection and inclusion, data extraction, assessment of study quality, assessment of the ability to combine trials, and statistical methods for data synthesis were examined.
RESULTS: A similar question was asked in all six SR. Different trials were selected for inclusion in the reviews mainly because of differences in the search strategies and selection criteria. Although similar methods for data extraction were utilised, differences were found both in the outcome measures and time-points selected for extraction. Methodological quality was not always formally assessed. Different statistical methods for data synthesis resulted in conflicting estimates of therapeutic effect.
CONCLUSIONS: Reasons for the inconsistency of results reported in the six SR were identified. Using the principles of the GRADE approach for estimating the therapeutic effect of HA in the treatment of OA of the knee, there is moderate evidence suggesting that further research is unlikely to change our confidence in the estimate of the effect. In the balance of benefit to harm, the trade-off is probable benefit with respect to pain reduction and physical function improvement with low risk of harm.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448701     DOI: 10.1016/j.joca.2007.01.022

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  27 in total

1.  Cochrane in CORR®: Viscosupplementation for the treatment of osteoarthritis of the knee.

Authors:  Nathan Evaniew; Nicole Simunovic; Jon Karlsson
Journal:  Clin Orthop Relat Res       Date:  2013-11-12       Impact factor: 4.176

Review 2.  Viscosupplementation for osteoarthritis: a primer for primary care physicians.

Authors:  M Carrington Reid
Journal:  Adv Ther       Date:  2013-11-08       Impact factor: 3.845

3.  Osteoarthritis: Hyaluronic acid is not effective in symptomatic hip OA.

Authors:  David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2009-07       Impact factor: 20.543

Review 4.  [Injection treatment with hyaluronic acid].

Authors:  J Jerosch
Journal:  Z Rheumatol       Date:  2015-11       Impact factor: 1.372

5.  Safety and efficacy of bi-annual intra-articular LBSA0103 injections in patients with knee osteoarthritis.

Authors:  Jin Kyu Lee; Chong-Hyuk Choi; Kwang-Jun Oh; Hee-Soo Kyung; Ju-Hyung Yoo; Chul-Won Ha; Seong-Il Bin; Seung-Baik Kang; Myung Ku Kim; Ju-Hong Lee; Myung Chul Lee
Journal:  Rheumatol Int       Date:  2017-08-22       Impact factor: 2.631

Review 6.  Effectiveness of intra-articular therapies in osteoarthritis: a literature review.

Authors:  Peter Wehling; Christopher Evans; Jana Wehling; William Maixner
Journal:  Ther Adv Musculoskelet Dis       Date:  2017-06-20       Impact factor: 5.346

7.  Prospective trial of autologous conditioned plasma versus hyaluronan plus corticosteroid for elbow osteoarthritis in dogs.

Authors:  Samuel P Franklin; James L Cook
Journal:  Can Vet J       Date:  2013-09       Impact factor: 1.008

8.  Hylan g-f 20: review of its safety and efficacy in the management of joint pain in osteoarthritis.

Authors:  A Migliore; F Giovannangeli; M Granata; B Laganà
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2010-09-20

9.  Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO).

Authors:  Raghu Raman; Yves Henrotin; Xavier Chevalier; Alberto Migliore; Jörg Jerosch; Jordi Montfort; Hervé Bard; Dominique Baron; Pascal Richette; Thierry Conrozier
Journal:  Cartilage       Date:  2017-02-01       Impact factor: 4.634

10.  Evaluation of symptomatic slow-acting drugs in osteoarthritis using the GRADE system.

Authors:  Olivier Bruyère; Nansa Burlet; Pierre D Delmas; René Rizzoli; Cyrus Cooper; Jean-Yves Reginster
Journal:  BMC Musculoskelet Disord       Date:  2008-12-16       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.